Mark Woodruff

1.0k citations
10 papers · 574 · 1 hit paper · h-index 5

Impact in

    • Lymphoma Diagnosis and Treatment
    • Epigenetics and DNA Methylation
    • Histone Deacetylase Inhibitors Research
    • Cancer-related gene regulation
    • Protein Degradation and Inhibitors
    • Chromatin Remodeling and Cancer
    • RNA modifications and cancer

Papers in

    • Cardiac electrophysiology and arrhythmias 3
    • Cardiac pacing and defibrillation studies 2
    • Cardiovascular Function and Risk Factors 2
    • Cardiomyopathy and Myosin Studies 2
    • Cardiac, Anesthesia and Surgical Outcomes 1
    • Ion channel regulation and function 2
    • Chromatin Remodeling and Cancer 1

Mark Woodruff

8 papers receiving 553 citations

Mark Woodruff's Hit Papers

Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study 2018 · 469 citations
4690+2+5Years since publication100200300400

Peers

Mark Woodruff
Comparison fields: 5 of 59
  • Pathology and Forensic Medicine 108
  • Molecular Biology 339
  • Oncology 104
  • Cancer Research 56
  • Cardiology and Cardiovascular Medicine 75
Replace C Rimbaut with:
C Rimbaut France
Joyce J. B. C. van Beers Netherlands
Shande Tang United States
U. Matulonis United States
Monica Lencioni Italy
Maciej Kaźmierczak Poland
Natalie Stickel Germany
Ling Lu China
Hideki Makino Japan
M.R. Sertoli Italy
Mark Woodruff relative to C Rimbaut France C Rimbaut's profile →
Citations per field
00.5×5×10×15×19×
C Rimbaut · 1×
Citations per year

Countries citing papers authored by Mark Woodruff

Since Specialization
Citations

This map shows the geographic impact of Mark Woodruff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Woodruff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Woodruff more than expected).

Fields of papers citing papers by Mark Woodruff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Woodruff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Woodruff. The network helps show where Mark Woodruff may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Woodruff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Woodruff Line = papers co-authored together Mark Woodruff links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Hit paper breakdown →
2018469
2 198461
3 198724
4 200012
5 19894
6 19951
7 19891
8 20101
9 20101
10 20140

About Mark Woodruff

Mark Woodruff is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Organic Chemistry, Surgery and Pathology and Forensic Medicine, having authored 10 papers that have together received 574 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (3 papers), Ion channel regulation and function (2 papers), Cardiac pacing and defibrillation studies (2 papers), Cardiovascular Function and Risk Factors (2 papers), Cardiomyopathy and Myosin Studies (2 papers), Cardiac, Anesthesia and Surgical Outcomes (1 paper), Pharmacological Effects and Assays (1 paper) and Chromatin Remodeling and Cancer (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (108 citations), Molecular Biology (339 citations), Oncology (104 citations), Cancer Research (56 citations) and Cardiology and Cardiovascular Medicine (75 citations). Mark Woodruff has collaborated with scholars based in United States, Brazil and France. Frequent co-authors include Alice McDonald, Scott Ribich, Antoîne Italiano, Carlo Lucchesi, Peter Ho, Benjamin Suttle, Maud Toulmonde, Jean‐Charles Soria, Jean‐Marie Michot and Andréa Varga. Their work appears in journals such as The American Journal of Cardiology, Journal of Cardiovascular Pharmacology, Journal of the American College of Cardiology, Rapid Communications in Mass Spectrometry and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact